Search This Blog

Saturday, February 27, 2021

UBS Upgrades AstraZeneca (AZN:LN) (AZN) to Buy

 UBS analyst Michael Leuchten upgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Neutral to Buy on 'Much Cleaner Pro-Forma Profile'.

https://www.streetinsider.com/Analyst+Comments/UBS+Upgrades+AstraZeneca+%28AZN%3ALN%29+%28AZN%29+to+Buy+on+Much+Cleaner+Pro-Forma+Profile/18030620.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.